AsclepiX Completes Enrollment in DISCOVER Trial for nAMD
06 May 2024 //
GLOBENEWSWIRE
AsclepiX Raises $10 Million to Advance Phase 1/2a Clinical Study of AXT107
26 Jul 2023 //
GLOBENEWSWIRE
AsclepiX Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self
05 Jan 2021 //
EYEWIRE